From leukemias, to lymphomas and myelomas, see how cytogenetic laboratories and key opinion leader (KOL) networks in different countries have implemented OGM across multiple clinical research applications and how the workflow performs in comparison to traditional cytogenetic and molecular methods. Hear from experts building the framework around OGM implementation and the added value in precision, sensitivity and understanding of novel, driver structural variants in heme malignancy applications.

Ravindra Kolhe, MD, PhD, FACP  |  Georgia Cancer Center

Wahab A. Khan, PhD, FACMG  |  Dartmouth-Hitchcock Medical Center

Amber Verhasselt  |  PhD Student, KU Leuven

Klaudia Starosz  |  PhD Student, Medical University of Łódź

Gokce A. Toruner, MD, PhD, FACMG  |  Professor, University of Texas MD Anderson Cancer Center

Elly De Vlieghere, PhD, MSc  |  Molecular Biologist, AZ Sint-Jan Brugge

Anna Maria Puiggros Metje  |  Biologist Assistant, Molecular Cytogenetics Laboratory, Hospital Del Mar

Hosted By
Alka Chaubey, PhD, FACMG  |  Chief Medical Officer, Bionano

Dana Jaber, PhD | Sr. Clinical Affairs Scientist & Customer Success Manager - EMEA, Bionano

Session recording will be available On-Demand at the Bionano Youtube page on Monday, March 2 at 10 AM PST. The live Q&A Panel Discussion will not be available on demand.

Discover how OGM performs for the most challenging Heme malignancy indications, such as multiple myeloma and lymphomas, and see the latest OGM data and results from multiple groundbreaking studies. See how experts are utilizing Bionano’s workflow to unveil pathogenic & driver structural variants in solid tumors such as breast & ovarian cancers and soft tissue tumors. Also, discover how OGM is playing a key role as a quality control (QC) tool for assessing the genome integrity of various cell bioprocessing applications. 

Hippolyte Guerineau, PharmD  |  Centre Hospitalier de Versailles

Agnes Daudignon, PhD  |  CHU de Lille

Ying S. Zou, MD, PhD, FACMG | Director of Cancer Genetics Laboratory, The Johns Hopkins University School of Medicine

Alejandro Berenguer Rubio, MD  |  Researcher, Laboratory of Cytogenetics, Instituto de Investigación Sanitaria La Fe (IIS La Fe)

Darren "Ben" Finlay, PhD  |  Research Associate Professor, Sanford Burnham Prebys Medical Discovery Institute

James Haldane, MSc  |  Lead Scientist, iPSC Platform, iPSC Platform bit.bio

Annelise Bennaceur Griscelli   |  Professor, CEO, CiTHERA Center for iPS Cell Therapies, Paris Saclay University INSERM

Marc-Henri Stern, MD, PhD  |  DRCE Emeritus, Institut Curie

Phillip D. Michaels, MD  |  Medical Director, CAMD Translational Biomarker Core, Associate Pathologist, Brigham and Women’s Hospital and Harvard Medical School

Adrian Dubuc, PhD, FACMG  |  Vice Chair for Clinical Research (Cytogenetics/Genomics), Associate Professor of Oncology, Roswell Park Comprehensive Cancer Center

Hosted By
Alka Chaubey, PhD, FACMG  |  Chief Medical Officer, Bionano

Dana Jaber, PhD | Sr. Clinical Affairs Scientist & Customer Success Manager - EMEA, Bionano

Session recording will be available On-Demand at the Bionano Youtube page on Monday, March 2 at 12 PM PST. The live Q&A Panel Discussion will not be available on demand.

Become inspired by genetic disease research, including the rare and unresolved, where OGM is key to the discovery of relevant variants after multiple other traditional methods had failed to provide answers. Receive updates from the OGM global base of users from Japan, India, Italy, France, Turkey, and US, where OGM was instrumental in providing answers for the analysis of pre-natal, post-natal samples, and reproductive disorders and beyond.  

Yassmine Akkari, PhD, FACMG  |  Nationwide Children's Hospital

Debopriya Chakraborty   |  Molecular Diagnostics Post-doctoral Fellow, Dartmouth-Hitchcock Medical Center

Walaa Darwiche, PhD  |  Research and Development Engineer, CHU Amiens - Picardie

Li Fu, MD  |  PhD Student, Department of Human Genetics, Yokohama City University Graduate School of Medicine

Laila El Khattabi, PhD, PharmD  |  Clinical Associate Professor, Sorbonne University APHP Hospitals and Paris Brain Institute

Karthik Bharadwaj Tallapaka, MD, DrNB  |  Senior Scientist, Centre for Cellular and Molecular Biology

Bruna Burssed, MSc  |  PhD Student, Universidade Federal de São Paulo (UNIFESP) and RadboudUMC

Mehmet Burak Mutlu, MD  |  Medical Genetics Specialist, Detagen Genetic Diseases Diagnosis and Evaluation Center

Nikhil Sahajpal, PhD, FACMG  |  Assistant Director, Cytogenetics and Molecular Laboratories, Greenwood Genetic Center

Hosted By
Alka Chaubey, PhD, FACMG  |  Chief Medical Officer, Bionano

Dana Jaber, PhD | Sr. Clinical Affairs Scientist & Customer Success Manager - EMEA, Bionano

Session recording will be available On-Demand at the Bionano Youtube page on Monday, March 2 at 12 PM PST. The live Q&A Panel Discussion will not be available on demand.

Learn about Bionano products, including Ionic, Saphyr, Stratys, and VIA, directly from our customers. Key opinion leaders from US, Canada, and Netherlands will share their experience and data from isolating FFPE DNA from Ionic (isotachophoresis) workflow for downstream NGS applications, novel, semi-automated ultra-high molecular DNA isolation by the Ionic methos for OGM, customer experience using the high throughput Stratys system and how customers are using the VIA software solutions for heme malignancies and constitutional genetic disease applications. Don’t miss the chance to discover an interesting tool (OMKAR) to create a digital karyotype of OGM data of rearranged chromosomes! 

Alexander Hoischen  |  Professor, Genomic Technologies for Immune-Mediated and Infectious Diseases, Radboudumc

Chantal Courtemanche, PhD  |  Scientist, Molecular Diagnostics Laboratory, CHU de Québec / Université Laval

Vineet Bafna, PhD  |  Professor Computer Science & Engineering, University of California, San Diego

Brandon M. Shaw, PhD, FACMG, DABMGG  |  Laboratory Director, Cytogenomics/Molecular Genetics; Program Director, Laboratory Genetics and Genomics, Henry Ford Health

Elizabeth McCready, PhD, PCCMG  |  Clinical Laboratory Genetics Discipline Director/ Professor, Hamilton Health Sciences/ McMaster University

Eddy de Boer  |  Researcher, PhD Candidate, UMCG

Arjan Buijs  |  Laboratory Specialist UMCG

Adam C. Smith, PhD, FCCMG, FACMG, erCLG  |  Clinical Laboratory Director (Cytogenetics), Center for Molecular Biology and Pathology, Labcorp, NC, USA

Hosted By
Alka Chaubey, PhD, FACMG  |  Chief Medical Officer, Bionano

Dana Jaber, PhD  |  Sr. Clinical Affairs Scientist & Customer Success Manager - EMEA, Bionano

Session recording will be available On-Demand at the Bionano Youtube page on Monday, March 2 at 12 PM PST. The live Q&A Panel Discussion will not be available on demand.